Brown Advisory Inc. Boosts Stock Holdings in Encompass Health Co. (NYSE:EHC)

Brown Advisory Inc. grew its position in shares of Encompass Health Co. (NYSE:EHCGet Rating) by 2.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,185,743 shares of the company’s stock after acquiring an additional 32,658 shares during the quarter. Brown Advisory Inc. owned 1.19% of Encompass Health worth $84,272,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently bought and sold shares of the company. M&T Bank Corp purchased a new position in shares of Encompass Health in the 1st quarter worth about $296,000. Trilantic Capital Management L.P. purchased a new position in shares of Encompass Health in the 1st quarter worth about $2,351,000. Russell Investments Group Ltd. boosted its holdings in shares of Encompass Health by 16.6% in the 1st quarter. Russell Investments Group Ltd. now owns 463,097 shares of the company’s stock worth $32,927,000 after buying an additional 65,826 shares during the last quarter. Advisor Group Holdings Inc. boosted its holdings in shares of Encompass Health by 7.9% in the 1st quarter. Advisor Group Holdings Inc. now owns 21,261 shares of the company’s stock worth $6,576,000 after buying an additional 1,549 shares during the last quarter. Finally, Commonwealth Equity Services LLC boosted its holdings in shares of Encompass Health by 17.7% in the 1st quarter. Commonwealth Equity Services LLC now owns 5,161 shares of the company’s stock worth $367,000 after buying an additional 776 shares during the last quarter. 91.70% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on EHC shares. TheStreet cut Encompass Health from a “b-” rating to a “c+” rating in a research note on Tuesday, June 28th. BMO Capital Markets lowered their price objective on Encompass Health from $83.00 to $65.00 and set an “outperform” rating on the stock in a research note on Thursday. Deutsche Bank Aktiengesellschaft decreased their price target on Encompass Health from $80.00 to $62.00 in a research report on Wednesday. Credit Suisse Group decreased their price target on Encompass Health from $83.00 to $82.00 and set an “outperform” rating on the stock in a research report on Friday, June 10th. Finally, Stephens decreased their price target on Encompass Health from $78.00 to $74.00 and set an “overweight” rating on the stock in a research report on Tuesday, June 21st. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average price target of $74.60.

Encompass Health Stock Up 0.1 %

EHC stock opened at $52.91 on Friday. The company has a current ratio of 1.24, a quick ratio of 1.26 and a debt-to-equity ratio of 1.29. The company’s 50 day moving average is $54.14 and its 200 day moving average is $62.81. The stock has a market cap of $5.28 billion, a price-to-earnings ratio of 16.18, a price-to-earnings-growth ratio of 2.54 and a beta of 0.91. Encompass Health Co. has a 1-year low of $44.33 and a 1-year high of $81.45.

Encompass Health (NYSE:EHCGet Rating) last issued its earnings results on Monday, August 1st. The company reported $0.89 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.97 by ($0.08). The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Encompass Health had a return on equity of 16.20% and a net margin of 6.22%. The firm’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.17 EPS. Sell-side analysts predict that Encompass Health Co. will post 2.84 EPS for the current fiscal year.

Encompass Health Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Monday, October 3rd will be paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 1.13%. The ex-dividend date is Friday, September 30th. Encompass Health’s dividend payout ratio is currently 34.25%.

Encompass Health Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

See Also

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.